Equities

bluebird bio Inc

bluebird bio Inc

Actions
  • Price (EUR)0.445
  • Today's Change0.002 / 0.38%
  • Shares traded1.00k
  • 1 Year change-85.00%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320212020
ASSETS
Cash And Short Term Investments2223001,151
Total Receivables, Net----0.40
Total Inventory230--
Prepaid expenses152637
Other current assets, total221126
Total current assets2823371,216
Property, plant & equipment, net267101347
Goodwill, net5.655.6513
Intangibles, net10010
Long term investments097123
Note receivable - long term------
Other long term assets117.7817
Total assets6195941,781
LIABILITIES
Accounts payable182622
Accrued expenses89124150
Notes payable/short-term debt000
Current portion long-term debt/capital leases85----
Other current liabilities, total8.123.4332
Total current liabilities200153204
Total long term debt3800
Total debt12200
Deferred income tax------
Minority interest------
Other liabilities, total18767223
Total liabilities425220426
SHAREHOLDERS EQUITY
Common stock1.910.710.67
Additional paid-in capital4,4554,0964,260
Retained earnings (accumulated deficit)(4260)(3720)(2901)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1.8)(2.91)(5.51)
Total equity1953741,355
Total liabilities & shareholders' equity6195941,781
Total common shares outstanding1937166
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.